J. Shetye

931 total citations
30 papers, 698 citations indexed

About

J. Shetye is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, J. Shetye has authored 30 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in J. Shetye's work include Glycosylation and Glycoproteins Research (6 papers), Colorectal and Anal Carcinomas (6 papers) and Gastric Cancer Management and Outcomes (6 papers). J. Shetye is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Colorectal and Anal Carcinomas (6 papers) and Gastric Cancer Management and Outcomes (6 papers). J. Shetye collaborates with scholars based in Sweden, Denmark and Italy. J. Shetye's co-authors include Peter Biberfeld, Tiit Mathiesen, Staffan Holmin, Carlos Rubio-Terrés, Håkan Mellstedt, Birger Christensson, Peter Ragnhammar, Jan‐Erik Frödin, Jan Fagerberg and Kenneth Smedh and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Histochemistry & Cytochemistry and Leukemia.

In The Last Decade

J. Shetye

30 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Shetye Sweden 15 255 216 209 161 108 30 698
E Aghai Israel 15 148 0.6× 108 0.5× 161 0.8× 28 0.2× 58 0.5× 52 1.0k
Margarita Palutke United States 21 296 1.2× 262 1.2× 172 0.8× 48 0.3× 54 0.5× 52 1.1k
María A. Saornil Spain 18 152 0.6× 52 0.2× 207 1.0× 223 1.4× 37 0.3× 55 777
Veer Singh Mehta India 18 106 0.4× 92 0.4× 206 1.0× 46 0.3× 294 2.7× 44 1.0k
Maria Valeria Cherchi Italy 16 101 0.4× 474 2.2× 181 0.9× 143 0.9× 30 0.3× 35 1.0k
Wang Cy China 9 106 0.4× 170 0.8× 179 0.9× 64 0.4× 54 0.5× 36 568
Yoony Y. J. Gent Netherlands 12 119 0.5× 378 1.8× 220 1.1× 65 0.4× 69 0.6× 18 925
J. Woody Germany 6 102 0.4× 320 1.5× 96 0.5× 70 0.4× 26 0.2× 7 763
Lucy Chilton United Kingdom 14 266 1.0× 118 0.5× 454 2.2× 29 0.2× 18 0.2× 21 1.7k
S. Bubel Germany 8 160 0.6× 166 0.8× 132 0.6× 19 0.1× 31 0.3× 9 698

Countries citing papers authored by J. Shetye

Since Specialization
Citations

This map shows the geographic impact of J. Shetye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Shetye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Shetye more than expected).

Fields of papers citing papers by J. Shetye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Shetye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Shetye. The network helps show where J. Shetye may publish in the future.

Co-authorship network of co-authors of J. Shetye

This figure shows the co-authorship network connecting the top 25 collaborators of J. Shetye. A scholar is included among the top collaborators of J. Shetye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Shetye. J. Shetye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hojjat‐Farsangi, Mohammad, Amir Hossein Daneshmanesh, Abdul Salam Khan, et al.. (2018). First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells. Leukemia. 32(10). 2291–2295. 38 indexed citations
2.
Tsekrekos, Andrianos, Sönke Detlefsen, Robert H. Riddell, et al.. (2018). Histopathologic tumor regression grading in patients with gastric carcinoma submitted to neoadjuvant treatment: results of a Delphi survey. Human Pathology. 84. 26–34. 24 indexed citations
3.
Smedh, Kenneth, et al.. (2017). Detection of Free Cancer Cells in Pelvic Lavage with Double Immunocytochemistry at Rectal Cancer Surgery. Anticancer Research. 37(4). 1563–1568. 1 indexed citations
4.
Nikberg, Maziar, et al.. (2015). Circumferential Resection Margin as a Prognostic Marker in the Modern Multidisciplinary Management of Rectal Cancer. Diseases of the Colon & Rectum. 58(3). 275–282. 30 indexed citations
5.
Rubio-Terrés, Carlos, et al.. (2014). p53 up-regulation during colorectal carcinogenesis.. PubMed. 34(12). 6973–9. 6 indexed citations
6.
Ragnhammar, Peter, Jan Fagerberg, Jan‐Erik Frödin, et al.. (1999). Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma. Cancer Immunology Immunotherapy. 48(8). 463–470. 16 indexed citations
7.
Mellstedt, Håkan, Jan Fagerberg, Jan‐Erik Frödin, et al.. (1999). Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors. Current Opinion in Hematology. 6(3). 169–169. 40 indexed citations
8.
Shetye, J., et al.. (1996). Retrieval of leukocyte antigens in paraffin-embedded rat tissues.. Journal of Histochemistry & Cytochemistry. 44(7). 767–776. 18 indexed citations
9.
Ragnhammar, Peter, Jan Fagerberg, I Magnusson, et al.. (1995). Subcutaneous Interleukin-2 and Alpha-Interferon in Advanced Colorectal Carcinoma. - A Phase II Study. PubMed. 10(1). 5–12. 3 indexed citations
10.
Holmin, Staffan, Tiit Mathiesen, J. Shetye, & Peter Biberfeld. (1995). Intracerebral inflammatory response to experimental brain contusion. Acta Neurochirurgica. 132(1-3). 110–119. 175 indexed citations
11.
Rubio-Terrés, Carlos & J. Shetye. (1994). Flat adenoma-adenocarcinoma sequence in the colon of rats. Diseases of the Colon & Rectum. 37(12). 1300–1306. 23 indexed citations
12.
Shetye, J., Tiit Mathiesen, Jan Fagerberg, & Carlos Rubio-Terrés. (1994). Ear tumours induced by experimental carcinogenesis in the rat: excision prevents early death. International Journal of Colorectal Disease. 9(3). 125–127. 3 indexed citations
13.
Rubio-Terrés, Carlos, J. Shetye, & Edgar Jaramillo. (1994). Histogenesis of small colonic adenocarcinomas. Journal of Surgical Oncology. 56(1). 59–62. 10 indexed citations
14.
Shetye, J., et al.. (1992). Normal colon of Sprague-Dawley rats. Anatomy and Embryology. 185(1). 69–76. 3 indexed citations
15.
Mellstedt, Hákan, Peter Ragnhammar, Giuseppe Masucci, et al.. (1991). Therapy of Colorectal Carcinoma with Monoclonal Antibodies (MAb17-1A) Alone and in Combination with Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF). Acta Oncologica. 30(8). 923–931. 15 indexed citations
16.
Mellstedt, Håkan, Jan‐Erik Frödin, Peter Ragnhammar, et al.. (1989). The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma. Medical Oncology and Tumor Pharmacotherapy. 6(1). 99–107. 12 indexed citations
17.
Shetye, J., et al.. (1989). The tumor-associated antigens BR55-2, GA73-3 and GICA 19-9 in normal and corresponding neoplastic human tissues, especially gastrointestinal tissues.. PubMed. 9(2). 395–404. 39 indexed citations
18.
Mellstedt, Håkan, Giuseppe Masucci, C. Lindemalm, et al.. (1989). Monoclonal antibodies (MAb 17-1A) for the treatment of patients with metastatic colorectal carcinomas.. PubMed. 549. 63–70. 6 indexed citations
19.
Shetye, J., et al.. (1988). Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). Cancer Immunology Immunotherapy. 27(2). 154–62. 51 indexed citations
20.
Biberfeld, Peter, Birger Christensson, Jan‐Erik Frödin, et al.. (1987). Clinical experience with monoclonal antibodies alone. Treatment of col0-rectal carcinomas with Mab 17-1A AND T CELL MALIGNANCIES WITH anti-idiotypic antibodies. International Journal of Radiation Oncology*Biology*Physics. 13. 71–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Aghai Breakdown of academic impact, for papers by Margarita Palutke Breakdown of academic impact, for papers by María A. Saornil Breakdown of academic impact, for papers by Veer Singh Mehta Breakdown of academic impact, for papers by Maria Valeria Cherchi Breakdown of academic impact, for papers by Wang Cy Breakdown of academic impact, for papers by Yoony Y. J. Gent Breakdown of academic impact, for papers by J. Woody Breakdown of academic impact, for papers by Lucy Chilton Breakdown of academic impact, for papers by S. Bubel
Rankless by CCL
2026